Skip to main content
AKBA $0.42 +3.28%
AKBA logo
AKBA · Akebia Therapeutics, Inc.
Track AKBA — free
$0.42 +0.01 (+3.28%) At close · Nov 19 Play latest call Q3 2026 earnings call transcript
Market Cap
$117.26M
Shares
277.66M
Volume · Nov 19 2.75M Avg daily vol (3M) 8.17M
All webcasts

Earnings call · FY2023 Q4

Akebia Therapeutics, Inc. (AKBA) Q4 2023 Earnings Call

Concluded Jan 8, 2024
Jan 8, 2024
Period
FY2023 Q4
Runtime
—
Sources
2 artifacts
Revenue · derived Q4 $56.20M +0.9% YoY
Gross margin · derived Q4 66.8% -38.0 pp YoY
Net income · derived Q4 $612,000
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document